Next-generation regenerative therapy for ischemic stroke using peripheral blood mononuclear cells  

作　　者：Masato Kanazawa Itaru Ninomiya Yutaka Otsu Masahiro Hatakeyama 

机构地区：[1]Department of Neurology,Brain Research Institute,Niigata University,Niigata,Japan

出　　处：《Neural Regeneration Research》2024年第11期2341-2342,共2页中国神经再生研究（英文版）

基　　金：supported by the JSPS KAKENHI Grant-in-Aid for Scientific Research(Grant number:21K19441,22H03183)(to MK);Early-Career Scientists(Grant number:21K15185)(to IN)and(Grant number:20K16485)(to MH).

摘　　要：Stroke is the second leading cause of death and the third leading cause of disability worldwide after heart disease.Researchers predict that stroke deaths and permanent disabilities will increase worldwide by the year 2050.Single-target therapies may be insufficient,because ischemic cerebral injury involves several mechanisms.Cell-mediated therapies are ideal,because they target multiple cell types to enhance protection and recovery.

关 键 词：ISCHEMIC DEATH CEREBRAL 

分 类 号：R743.3[医药卫生—神经病学与精神病学]